Skip to content
10-Q

Quarterly Report

CALLISTO PHARMACEUTICALS INC

0001104659-11-046978

← back to feed
Filed
Aug 15, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Aug 12, 2011 158.52M sh
Capex Q2 2011 · Jun 30, 2011 $117.23K
Operating Cash Flow Q2 2011 · Jun 30, 2011 −$6.75M
Operating Cash Flow Q2 2011 · Jun 30, 2011 −$76.98M
Operating Cash Flow Q2 2011 · Jun 30, 2010 −$6.11M
Stockholders Equity Q2 2011 · Jun 30, 2011 $2.75M
Stockholders Equity Q2 2011 · Dec 31, 2010 $3.94M
Current Liabilities Q2 2011 · Jun 30, 2011 $6.69M
Current Liabilities Q2 2011 · Dec 31, 2010 $7.07M
Total Liabilities Q2 2011 · Jun 30, 2011 $14.65M
Total Liabilities Q2 2011 · Dec 31, 2010 $10.55M
Current Assets Q2 2011 · Jun 30, 2011 $1.82M
Current Assets Q2 2011 · Dec 31, 2010 $3.26M
Total Assets Q2 2011 · Jun 30, 2011 $1.91M
Total Assets Q2 2011 · Dec 31, 2010 $3.36M
Sga Expense Q2 2011 · Jun 30, 2011 $56.54M
Sga Expense Q2 2011 · Jun 30, 2010 $1.6M
Sga Expense Q2 2011 · Jun 30, 2010 $3.04M
Net Income Q2 2011 · Jun 30, 2011 −$120.73M
Net Income Q2 2011 · Jun 30, 2010 −$1.72M
Net Income Q2 2011 · Jun 30, 2010 −$19.89M
Operating Income Q2 2011 · Jun 30, 2011 −$111.91M
Operating Income Q2 2011 · Jun 30, 2010 −$6.01M
Operating Income Q2 2011 · Jun 30, 2010 −$8.64M
Shares Diluted Q2 2011 · Jun 30, 2010 54.42M sh
Shares Diluted Q2 2011 · Jun 30, 2010 54.15M sh
Cash And Equivalents Q2 2011 · Jun 30, 2010 $1.33M
Cash And Equivalents Q2 2011 · Dec 31, 2009 $7.21M